Related Experiment Video
Updated: Mar 10, 2026
Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles
Published on: April 8, 2012
Risks Associated With Lentiviral Vector Exposures and Prevention Strategies
Ryan Schlimgen1, John Howard, Dawn Wooley
1Partners HealthCare, Boston, Massachusetts (Dr Schlimgen); National Institute for Occupational Safety and Health, Washington, District of Columbia (Dr Howard); Wright State University, Detroit, Michigan (Dr Wooley); Emory University, Atlanta, Georgia (Ms Thompson); Dana Farber Cancer Institute (Dr Baden, Ms Byers); Brigham and Women's Hospital (Dr Baden); Harvard Medical School, Boston, Massachusetts (Drs Baden, Christiani, Gelfand, Vyas); University of California Los Angeles, Los Angeles, California (Drs Yang, Hudson); Massachusetts General Hospital (Drs Christiani, Gelfand, Vyas); Harvard TH Chan School of Public Health (Dr Christiani); Boston University School of Medicine, Boston (Dr Mostoslavsky); Massachusetts Institute of Technology, Cambridge (Dr Diamond); Environmental Health and Engineering (Ms Duane); Occupational and Environmental Health Network, Boston, Massachusetts (Dr Winters); Occupational Medicine consultant, Los Altos, California (Dr Fujimoto).
Lentiviral vectors (LVVs) pose occupational risks. This review offers a framework for assessing LVV exposure risks and recommends antiviral treatment for exposed staff.
Area of Science:
- Biotechnology
- Gene Therapy
- Occupational Health
Background:
- Lentiviral vectors (LVVs) are increasingly used in research and clinical settings.
- Occupational exposure risks from LVVs require thorough assessment.
- Existing data on adverse events from clinical studies inform risk evaluation.
Purpose of the Study:
- To review the potential risks associated with occupational exposure to lentiviral vectors.
- To provide a framework for risk assessment and communication for researchers and safety professionals.
- To offer recommendations for tracking exposures and managing potential harm.
Main Methods:
- Review of existing literature on lentiviral vector safety and adverse events.
- Development of a risk assessment and communication framework.
- Formulation of recommendations for occupational health and regulatory bodies.
Main Results:
- Lentiviral vectors present potential occupational hazards that necessitate careful management.
- A structured approach is proposed for evaluating and communicating LVV exposure risks.
- Antiviral drugs approved for HIV show theoretical benefit, with a recommended 7-day regimen of integrase inhibitors.
Conclusions:
- Effective risk management strategies are crucial for safe handling of lentiviral vectors.
- Standardized tracking of LVV exposures is needed to evaluate long-term outcomes.
- Prompt administration of specific antiviral therapies may mitigate risks following LVV exposure.
More Related Videos
16:04A Tetracycline-regulated Cell Line Produces High-titer Lentiviral Vectors that Specifically Target Dendritic Cells
Published on: June 19, 2013
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
